|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002395,
umls-concept:C0006935,
umls-concept:C0205210,
umls-concept:C0392747,
umls-concept:C0443172,
umls-concept:C0936012,
umls-concept:C1280500,
umls-concept:C1514923,
umls-concept:C1547011,
umls-concept:C1879746,
umls-concept:C1961905,
umls-concept:C1998467,
umls-concept:C2348867
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-6-16
|
|
pubmed:abstractText |
The Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) scale is widely used in Alzheimer trials. It assesses cognition, activities of daily living (ADLs), behavior and global functioning. To advance the understanding of relationships between the ADCS-CGIC and scores from other commonly used tools, this analysis investigated the ability of each domain to measure change. This was a hypothesis-forming study, designed to provide a basis for possible future research.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9824
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
406-12
|
|
pubmed:meshHeading |
pubmed-meshheading:20502014-Administration, Cutaneous,
pubmed-meshheading:20502014-Administration, Oral,
pubmed-meshheading:20502014-Aged,
pubmed-meshheading:20502014-Aged, 80 and over,
pubmed-meshheading:20502014-Alzheimer Disease,
pubmed-meshheading:20502014-Behavior,
pubmed-meshheading:20502014-Capsules,
pubmed-meshheading:20502014-Double-Blind Method,
pubmed-meshheading:20502014-Female,
pubmed-meshheading:20502014-Humans,
pubmed-meshheading:20502014-Male,
pubmed-meshheading:20502014-Mental Processes,
pubmed-meshheading:20502014-Middle Aged,
pubmed-meshheading:20502014-Neuroprotective Agents,
pubmed-meshheading:20502014-Neuropsychological Tests,
pubmed-meshheading:20502014-Phenylcarbamates,
pubmed-meshheading:20502014-Randomized Controlled Trials as Topic,
pubmed-meshheading:20502014-Retrospective Studies,
pubmed-meshheading:20502014-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis.
|
|
pubmed:affiliation |
Mary S. Easton Center for Alzheimer's Disease Research at UCLA, Los Angeles, CA 90095-7226, USA. jcummings@mednet.ucla.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
